CANTOURAGE GROUP SE

Cantourage (HIGH1.DE) remains flat at €5.04, with thin liquidity and a downward bias after falling 13.44% this month. Investors should watch for a strategic turnaround before adding to a stagnant medical‑cannabis stock.

Cantourage stalls at €5, a flat 0% move amid weak volume and declining investor confidence, showing why a medical‑cannabis firm needs a clear earnings plan and strategic partners to break the stagnation.